2 minute read | March.05.2024
25 minute read | February.26.2024
Women's & Reproductive Health
by Alice Hsu, Bill Hughes, Hari Raman, Albert Vanderlaan, Travis Cherry and Bobby Bee
9 minute read | February.01.2024
The Securities and Exchange Commission (the “SEC”) has finalized its long-awaited rules regarding special purpose acquisition companies (“SPAC”).
by Stephen Thau, Albert Vanderlaan and George Pothoulakis
6 minute read | January.30.2024
Reverse mergers have helped biotech companies access public markets, but recent SEC positions are threatening that path to going public.
1 minute read | 31 minute listen | January.04.2024
by Dr. Johannes Rüberg, EMBA, Carsten Bernauer and Dr. Stefan Schultes-Schnitzlein
7 minute read | November.21.2023
22 minute read | November.10.2023
by Mark Seneca
October.26.2023
by David Rhinesmith, Aaron Brecher and Alison Epperson
5 minute read | October.26.2023
The Department of Justice (DOJ) recently unveiled a policy for voluntary disclosure of misconduct in mergers and acquisitions (M&A).
by Kathryn Ryan, Samantha Goldberg-Seder and James Chou
October.06.2023
by Julia Apostle, Alexis Marraud des Grottes and Zac Padgett
9 minute read | September.18.2023
by Natasha Ahmed, Julia Apostle, Jennifer Criss and Benedikt Migdal
11 minute read | September.13.2023
